MyJournals.org - Science - Long-term effectiveness and safety of lacosamide as adjunctive therapy in children and adolescents with refractory epilepsy: a real-world study (BMC Pediatrics)
Mumbai (Maharashtra) [India], March 21 (ANI/PR Newswire): Glenmark Pharmaceuticals Inc., USA (Glenmark) has received final approval by the United States Food & Drug Administration (U.S
Epilepsy Drugs Market is projected to reach US$ 10.3 Billion by 2027. Global Forecast, Impact of COVID-19, Industry Trends, by Drugs Category, Country, Growth, Opportunity Company Analysis.